Cargando…
Oncolytic Viruses and the Immune System: The Dynamic Duo
Oncolytic viruses (OVs) constitute a new and promising immunotherapeutic approach toward cancer treatment. This therapy takes advantage of the natural propensity of most tumor cells to be infected by specific OVs. Besides the direct killing potential (oncolysis), what makes OV administration attract...
Autores principales: | Lemos de Matos, Ana, Franco, Lina S., McFadden, Grant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015832/ https://www.ncbi.nlm.nih.gov/pubmed/32071927 http://dx.doi.org/10.1016/j.omtm.2020.01.001 |
Ejemplares similares
-
Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020) -
Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
por: Rahman, Masmudur M., et al.
Publicado: (2021) -
Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
por: Everts, Anne, et al.
Publicado: (2020) -
Oncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma
por: Phelps, Michael P., et al.
Publicado: (2018) -
Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022)